A recent report reviewing all the promising biomarkers identified in tongue cancers have shown vimentin as one of the strongest biomarker with significant relevance as a marker with clinical utility [40] proving that it is an important marker of OTSCC which innately shows a higher propensity to metastasize confirming our reports. The gene discussed is VIM; the disease is tongue cancer.